UNSPSC 51282615: Cefquinome sulfate

This classification denotes a cephalosporin antibiotic with the molecular formula C23H24N6O5S2.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3858K104DQ. The term cefquinome sulfate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule cefquinome sulfate under HS 29419000 and SITC 54139. As of Q4 2014, CEFQUINOME SULFATE remains US FDA's Preferred Term for this commodity. Cefquinome sulfate bears US NLM identifiers UMLS ID C2825422 and NCI Concept Code C81032.

SMILES: CO/N=C(/C1CSC(N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4CCCC5C4CCCC5)C(=O)[O-].OS(=O)(=O)O.

UNSPSC 51282615 Cefquinome sulfate is a Commodity code that, based on recent state and local opportunities, does not reflect the actual pharmaceutical products being procured under its tag. The two most recent opportunities tagged with this code involve Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets (Illinois Department of Public Health) and Naloxone and Safe Drug Deactivation Systems (Seminole County, Florida), neither of which are cefquinome sulfate. The mismatch suggests that state and local procurement systems may be applying this code to broader pharmaceutical warehouse and public-health pharmaceutical supply categories rather than to the specific veterinary antibiotic the code nominally describes. State and local issuing bodies using this code appear to include state health departments and county government entities with public health procurement responsibilities, procuring through cooperative purchasing vehicles (MMCAP Infuse consortium in the Illinois case) and traditional competitive bidding processes (IFB).

Activity is geographically dispersed across at least Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 contract to Chartwell Rx LLC on August 28, 2026, through an IFB process for pharmaceutical warehouse supply via the MMCAP Infuse consortium, with an initial 12-month term and two optional renewal years. Seminole County, Florida released an IFB on June 30, 2026, seeking annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, though the response deadline listed in the record (July 26, 2023) predates the posting date and appears inconsistent. The code shows active pharmaceutical supply procurement but limited recent-opportunity density and potential misclassification within state and local procurement taxonomies.